(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:
Hereditary Angioedema
The purpose of this study is to show that C1-INH concentrate (an investigational product) shortens the time to onset of relief of symptoms of abdominal or facial HAE attacks, compared to placebo. You may participate in this study if you have a diagnosis of hereditary C1-INH deficiency, have a documented history of facial or abdominal attacks, and are age six years or older. Research site located in King of Prussia, Penn.
More Information
Please see http://www.centerwatch.com/patient/studies/cat653.html.
-----
Healthy Patient Studies
This is a DNA study for healthy Caucasians 18 or older with total cholesterol less than 200 mg/dl, glucose less than 126mg/dl, or blood pressure less than 140/90. Research site located in Pembroke Pines, Fla.
More Information
Please see http://www.centerwatch.com/patient/studies/phasei.html.
-----
Addictions
The purpose of this study is to test startle responses differences between people who gamble compulsively and those who do not. Participants will complete questionnaires about their gambling behaviors, provide a drug use and psychiatric history, and be assessed for startle response to environmental noise. Research site located in Los Angeles, Calif.
More Information
Please see http://www.centerwatch.com/patient/studies/cat219.html.
-----
Copyright 2005 CenterWatch. All rights reserved.
